In the Blogs: HIPAA HIPAA Hooray

Why It Matters

Healthcare providers will need to overhaul security programs, raising compliance costs but lowering breach risk, while expanded tax reporting and steep pharma tariffs force businesses to rethink cash‑flow and pricing strategies.

Key Takeaways

• HHS proposes biggest HIPAA Security Rule overhaul since 2013
• IRS IR‑2026‑46 extends Business Tax Accounts to governments and nonprofits
• Audit found $172.4 M in improper ITIN credits
• Trump’s tariff changes raise pharma import duties up to 100 %
• Dollar strength reshapes international stocks, gold, and portfolio returns

Pulse Analysis

The December 2024 HIPAA Security Rule proposal marks the most sweeping change in over a decade, reflecting the HHS Office for Civil Rights’ response to a wave of cyber‑incidents in hospitals and clinics. By mandating stronger encryption, multi‑factor authentication and continuous risk assessments, the rule pushes providers toward a more resilient security posture. While the compliance burden will rise—particularly for smaller practices—the move is expected to reduce the frequency and severity of data breaches, a trend that regulators and insurers are watching closely.

On the tax front, the IRS’s IR‑2026‑46 expansion of Business Tax Accounts opens a unified reporting framework to partnerships, state and local governments, tribal entities and tax‑exempt organizations. This streamlines filing but also widens the audit surface, as highlighted by the TIGTA review that identified $172.4 million in improper ITIN‑related credits. Tax professionals must now verify eligibility more rigorously and adjust client workflows to accommodate the broader filing base, ensuring that credit claims meet the tightened eligibility criteria.

Meanwhile, President Trump’s recent tariff adjustments—lowering some aluminum, steel and copper rates while imposing up to 100 % duties on certain pharmaceutical imports—reshape cost structures for manufacturers and importers. Coupled with a strong U.S. dollar influencing international equities and gold, firms face a dual challenge: managing higher input costs and navigating currency‑driven valuation shifts. Companies can mitigate exposure by revisiting supply‑chain contracts, exploring domestic sourcing, and leveraging tariff‑specific deductions where available. Proactive planning will be essential to preserve margins in this evolving trade environment.